Guardant Health, Inc. (GH)
USD 32.36
(-7.12%)
USD 32.36
(-7.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -433.3 Million USD | 20.16% |
| 2022 | -614.91 Million USD | -70.43% |
| 2021 | -359.62 Million USD | -58.37% |
| 2020 | -225.07 Million USD | -251.81% |
| 2019 | -54.93 Million USD | 17.39% |
| 2018 | -75.83 Million USD | -18.14% |
| 2017 | -75.3 Million USD | -78.15% |
| 2016 | -39.42 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -89.91 Million USD | 11.7% |
| 2024 Q1 | -88.97 Million USD | 41.37% |
| 2023 Q3 | -73.93 Million USD | -3.21% |
| 2023 FY | - USD | 20.16% |
| 2023 Q2 | -71.63 Million USD | 46.0% |
| 2023 Q1 | -132.64 Million USD | 4.35% |
| 2023 Q4 | -252.52 Million USD | -241.57% |
| 2022 Q1 | -115.4 Million USD | -61.05% |
| 2022 FY | - USD | -70.43% |
| 2022 Q4 | -138.68 Million USD | 8.41% |
| 2022 Q3 | -151.42 Million USD | 31.03% |
| 2022 Q2 | -219.55 Million USD | -90.24% |
| 2021 FY | - USD | -58.37% |
| 2021 Q4 | -71.65 Million USD | 29.22% |
| 2021 Q3 | -101.24 Million USD | -10.99% |
| 2021 Q2 | -91.22 Million USD | 10.21% |
| 2021 Q1 | -101.59 Million USD | -15.39% |
| 2020 Q4 | -88.04 Million USD | -24.66% |
| 2020 Q3 | -70.62 Million USD | -42.12% |
| 2020 Q2 | -49.69 Million USD | -84.04% |
| 2020 Q1 | -27 Million USD | -21.21% |
| 2020 FY | - USD | -251.81% |
| 2019 Q1 | -21.03 Million USD | 15.66% |
| 2019 Q4 | -22.27 Million USD | -121.45% |
| 2019 Q3 | -10.06 Million USD | 17.68% |
| 2019 FY | - USD | 17.39% |
| 2019 Q2 | -12.22 Million USD | 41.9% |
| 2018 Q4 | -24.93 Million USD | -17.63% |
| 2018 Q2 | -19.75 Million USD | -62.98% |
| 2018 Q1 | -12.11 Million USD | 9.28% |
| 2018 FY | - USD | -18.14% |
| 2018 Q3 | -21.2 Million USD | -7.35% |
| 2017 Q1 | -14.92 Million USD | 0.0% |
| 2017 FY | - USD | -78.15% |
| 2017 Q3 | -26.94 Million USD | -67.38% |
| 2017 Q2 | -16.09 Million USD | -7.9% |
| 2017 Q4 | -13.35 Million USD | 50.43% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | -102.854% |
| Prenetics Global Limited | -47.89 Million USD | -804.677% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -25584.944% |
| CareDx, Inc | -89.65 Million USD | -383.292% |
| Exact Sciences Corporation | 41.87 Million USD | 1134.733% |
| Exagen Inc. | -19.15 Million USD | -2162.335% |
| Inotiv, Inc. | -26.5 Million USD | -1534.743% |
| Biodesix, Inc. | -37.1 Million USD | -1067.844% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -17335.691% |
| Precipio, Inc. | -4.31 Million USD | -9934.854% |
| iSpecimen Inc. | -9.1 Million USD | -4659.648% |
| Natera, Inc. | -383.27 Million USD | -13.053% |
| Aspira Women's Health Inc. | -16.49 Million USD | -2527.524% |
| Standard BioTools Inc. | -54.45 Million USD | -695.683% |
| 23andMe Holding Co. | -291.87 Million USD | -48.456% |
| Castle Biosciences, Inc. | -45.02 Million USD | -862.387% |
| Personalis, Inc. | -96.8 Million USD | -347.597% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | -268.566% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -4417.81% |
| OpGen, Inc. | -29.51 Million USD | -1368.283% |
| T2 Biosystems, Inc. | -43.87 Million USD | -887.59% |
| Myriad Genetics, Inc. | -67.8 Million USD | -539.093% |
| ICON Public Limited Company | 1.63 Billion USD | 126.556% |
| NeoGenomics, Inc. | -17.6 Million USD | -2360.981% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -25584.944% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 135.585% |
| RadNet, Inc. | 292.78 Million USD | 247.994% |
| MDxHealth SA | -30.46 Million USD | -1322.164% |
| Psychemedics Corporation | -251 Thousand USD | -172531.474% |
| Illumina, Inc. | -608 Million USD | 28.733% |
| Check-Cap Ltd. | -17.64 Million USD | -2355.125% |
| Twist Bioscience Corporation | -176.7 Million USD | -145.214% |
| DarioHealth Corp. | -53.49 Million USD | -710.007% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -830.798% |
| Sera Prognostics, Inc. | -35.28 Million USD | -1127.945% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -4328.346% |
| OPKO Health, Inc. | -65.51 Million USD | -561.373% |
| Medpace Holdings, Inc. | 363.15 Million USD | 219.317% |
| Neogen Corporation | 182.59 Million USD | 337.301% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -4817.937% |
| Prenetics Global Limited | -47.89 Million USD | -804.677% |
| Mainz Biomed B.V. | -25.01 Million USD | -1632.444% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -5579.482% |
| Trinity Biotech plc | -24.09 Million USD | -1698.095% |
| Neuronetics, Inc. | -22.75 Million USD | -1803.884% |
| Sotera Health Company | 514.14 Million USD | 184.277% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -5579.482% |